Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028007
Filing Date
2019-08-01
Accepted
2019-08-01 16:45:03
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q thor-10q_20190630.htm 10-Q 2060875
2 EX-31.1 thor-ex311_6.htm EX-31.1 7902
3 EX-31.2 thor-ex312_7.htm EX-31.2 7700
4 EX-32.1 thor-ex321_8.htm EX-32.1 8542
  Complete submission text file 0001564590-19-028007.txt   5589438

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thor-20190630.xml EX-101.INS 1008220
6 XBRL TAXONOMY EXTENSION SCHEMA thor-20190630.xsd EX-101.SCH 48609
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thor-20190630_cal.xml EX-101.CAL 42853
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thor-20190630_def.xml EX-101.DEF 115986
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE thor-20190630_lab.xml EX-101.LAB 316988
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thor-20190630_pre.xml EX-101.PRE 234853
Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Filer) CIK: 0001609727 (see all company filings)

EIN.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38756 | Film No.: 19993262
SIC: 2834 Pharmaceutical Preparations